Antibody Aggregation: A Problem Within the Biopharmaceutical Industry and Its Role in AL Amyloidosis Disease
The Protein Journal · 2025-02 · 44 (1) · 1-20
DOI: 10.1007/s10930-024-10237-6 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The Protein Journal, online erschienen am 11.11.2024. Verfasst von Kate Sheehan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Trinity Biomedical Sciences Institute (TBSI), School of Biochemistry & Immunology, Trinity College Dublin, The University of Dublin, Dublin 2, Irelan…. Hauptthemen laut MEDLINE: Immunoglobulin Light-chain Amyloidosis, Antibodies, Monoclonal, Protein Aggregates. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 239 Literaturangaben. Gefördert von: Horizon 2020.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Trinity Biomedical Sciences Institute (TBSI), School of Biochemistry & Immunology, Trinity College Dublin, The University of Dublin, Dublin 2, Ireland.
- School of Genetics & Microbiology, Trinity College Dublin, The University of Dublin, Dublin 2, Ireland.
- Lonza Biologics Tuas Pte. Ltd., 35 Tuas South Ave 6, Singapore, 637377, Republic of Singapore.
- School of Microbiology and APC Microbiome Ireland, University College Cork, Cork, Ireland.
- Trinity Biomedical Sciences Institute (TBSI), School of Biochemistry & Immunology, Trinity College Dublin, The University of Dublin, Dublin 2, Ireland. mok1@tcd.ie.
- Centre for Research on Adaptive Nanostructures and Nanodevices (CRANN), Trinity College Dublin, The University of Dublin, Dublin 2, Ireland. mok1@tcd.ie.
Förderung
- Horizon 2020
Zitieren
APA
Sheehan, K., Jeon, H., Corr, S. C., Hayes, J. M., & Mok, K. H. (2025). Antibody Aggregation: A Problem Within the Biopharmaceutical Industry and Its Role in AL Amyloidosis Disease. The Protein Journal, 44(1), 1-20. https://doi.org/10.1007/s10930-024-10237-6
Vancouver
Sheehan K, Jeon H, Corr SC, Hayes JM, Mok KH. Antibody Aggregation: A Problem Within the Biopharmaceutical Industry and Its Role in AL Amyloidosis Disease. The Protein Journal. 2025;44(1):1-20. doi:10.1007/s10930-024-10237-6
BibTeX
@article{Sheehan2025,
author = {Sheehan, Kate and Jeon, Hyesoo and Corr, Sinéad C and Hayes, Jerrard M and Mok, K H},
title = {Antibody Aggregation: A Problem Within the Biopharmaceutical Industry and Its Role in AL Amyloidosis Disease},
journal = {The Protein Journal},
year = {2025},
volume = {44},
number = {1},
pages = {1--20},
doi = {10.1007/s10930-024-10237-6}
}
EUVIMED